Trials / Unknown
UnknownNCT05952050
Different Administration Routes of Dexmedetomidine on Postoperative Delirium
Effect of Different Administration Routes of Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing General Anesthesia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 65 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Intravenous dexmedetomidine has been reported to decrease the occurrence of postoperative delirium (POD) in elderly patients. Nevertheless, some previous studies have indicated that intratracheal dexmedetomidine and intranasal dexmedetomidine are also effective and convenient. The current study aimed to compare the effect of different administration routes of dexmedetomidine on POD in elderly patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | Different Administration Routes of Dexmedetomidine |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2023-08-01
- Completion
- 2023-09-30
- First posted
- 2023-07-19
- Last updated
- 2023-07-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05952050. Inclusion in this directory is not an endorsement.